
View larger version (79K):
[in a new window]
|
Fig. 3. Head defects induced by McerP-BMP4, Xnr1 and Xwnt8 microinjection in the
frog embryo. Embryos were injected at the four-to-eight-cell stage in the two
dorsal-vegetal blastomeres. (A-C) Injection of 80 pg of CMV.BMP4 (A; 100%,
n=22), CMV.Xnr1(B; 94%, n=17) and CMV.Xwnt8 (C; 20%,
n=25) led to very severe phenotypes. (D-F) Injection of 20 pg (F;
60%, n=20), 40 pg (E; 62%, n=34) and 80 pg (D; 50%,
n=24) of McerP-BMP4 showed a concentration dependent increase in head
truncation. (G-I) A progressive head reduction and loss of eye were observed
when 20 pg (I; 100%, n=26), 40 pg (H; 24%, n=21) and 80 pg
(G; 59%, n=34) of McerP-Xnr1. (J-L) Increasing the amount of
McerP-Xwnt8 from 20 pg (L; 60%, n=25) to 40 pg (K; 62%,
n=28) to 80 pg (J; 74%, n=19) resulted in loss of cement
gland and cyclopia and ultimately in complete truncation of the head. (M,N)
Synergistic effect of McerP-BMP4, Xnr1 and Xwnt8 is shown by the coinjection
of 8 pg (N; 65%, n=23) and 20 pg (M; 63%, n=46) of each
construct which resulted in more severe defects than the ones observed in
embryos injected with equal amounts of the individual constructs (F,I and L).
20 pg of McerP-lacZ was coinjected to access the correct targeting of
the promoters to the ADE (yellow arrowheads in E, H and K).
|